Drug Type Small molecule drug |
Synonyms RPR-101511, RPR-101511A |
Target |
Mechanism PDGFR antagonists(Platelet-derived growth factor receptor antagonists), RTK inhibitors(Receptor protein-tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13NO2S |
InChIKeyKGGRQYJJHXVWSI-UHFFFAOYSA-N |
CAS Registry146535-06-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Vascular restenosis | Discovery | US | - |